Anton A. H. P. Megens

Author

Also Known As

A A Megens, A. A. H. P. Megens, A. Megens, A.A. Megens, A.A.H.P. Megens, Anton A. H. P. Megens, Anton A. Megens, Anton A.H.P Megens, Anton A.H.P. Megens, Anton Megens

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Janssen (Belgium)Johnson & Johnson (United States)Addex Therapeutics (Switzerland)

About

Anton A. H. P. Megens is an author at Janssen (Belgium) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	20	1.5K
2	Social Sciences	6	6	693
3	Health Sciences	3	3	115
4	Natural Sciences	3	3	142
5	Engineering	1	1	42

Anton A. H. P. Megens

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors J E Leysen, Paul M. F. Janssen, Alain Schotte, Psychopharmacology Molecular PharmacologyPsychoactive DrugPsychiatryMedicineAntipsychotic Drugs	1993	335
Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography Alain Schotte, P.F.M. Janssen, Anton A. H. P. Megens, Brain Research Psychoactive DrugNeuroanatomyMedicineQuantitative AutoradiographyPsychopharmacology	1993	225
Regional brain distribution of risperidone and its active metabolite 9-hydroxy-risperidone in the rat Ludy E.C. Van Beijsterveldt, R Geerts, Josée E. Leysen, Psychopharmacology Psychoactive DrugNeuroanatomyMedicinePsychotropic MedicationPsychopharmacology	1994	176
The Differential Effects of Atypical Antipsychotics on Prolactin Elevation Are Explained by Their Differential Blood-Brain Disposition: A Pharmacological Analysis in Rats Shitij Kapur, Xavier Langlois, Petra Vinken, Journal of Pharmacology and Experimental Therapeutics	2002	157
Pharmacological profile of ritanserin: A very specific central serotonin S<sub>2</sub>‐antagonist F. Awouters, C. J. E. Niemegeers, Anton A. H. P. Megens, Drug Development Research Molecular PharmacologyPsychoactive DrugMedicineMast Cell SerotoninMonoamine Neurotransmitters	1988	139
Effects of mGlu1 receptor blockade on anxiety-related behaviour in the rat lick suppression test Thomas Steckler, Hilde Lavreysen, Ana M.M. Oliveira, Psychopharmacology Stress HormonePsychiatryBehavioral NeuroscienceMglu1 Receptor BlockadeAnxiety-related Behaviour	2004	90
Discovery of 3-Cyclopropylmethyl-7-(4-phenylpiperidin-1-yl)-8-trifluoromethyl[1,2,4]triazolo[4,3-<i>a</i>]pyridine (JNJ-42153605): A Positive Allosteric Modulator of the Metabotropic Glutamate 2 Receptor José M. Cid, Gary Tresadern, Juan A. Vega, Journal of Medicinal Chemistry Rem Sleep StatePharmacotherapyMglu2 Receptor PamsExperimental PharmacologyPre-clinical Pharmacology	2012	84
New 2-substituted 1,2,3,4-tetrahydrobenzofuro[3,2-c]pyridine having highly active and potent central α2-antagonistic activity as potential antidepressants Ludo Kennis, François Bischoff, Carolus J. Mertens, Bioorganic & Medicinal Chemistry Letters	2000	68
Pharmacological Characterization of JNJ-40068782, a New Potent, Selective, and Systemically Active Positive Allosteric Modulator of the mGlu2 Receptor and Its Radioligand [3H]JNJ-40068782 Hilde Lavreysen, Xavier Langlois, A. Ahnaou, Journal of Pharmacology and Experimental Therapeutics	2013	62
Comparison of the Analgesic and Intestinal Effects of Fentanyl and Morphine in Rats Anton A. H. P. Megens, Kamiel S. K. Artois, Jef Vermeire, Journal of Pain and Symptom Management Intestinal EffectsHealth SciencesFentanylPain MedicineMedicine	1998	62

Page 1